AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2023
Sep 6, 2023
34519_dirs_2023-09-06_5e6928a8-ebaa-4812-8d8f-46752f33aa01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2023-09-06
Reporting Person: Tomsche David Scott (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Common stock $0.10 per value per share | D | 3100 | $4.7541 | Acquired | 103606 | Direct |
Footnotes
F1: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
Jul 9
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 17
Call Transcript
2026
Jun 11
Regulatory Filings
2026
Jun 10
Call Transcript
2026
May 15
Report Publication Announcement
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 14